ArticleRwanda journal of medicine and health sciences2024
Effectiveness of Smartphone Application "Gororokapp" for Type 2 Diabetes Patients' Self-Management in Rwanda: A Randomized Controlled Trial.
Article in Rwanda journal of medicine and health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 2 diabetes has become a public health concern, representing more than 90% of all types of diabetes and affecting 536.6 million people worldwide in 2021. It is a disabling condition and is considered a major risk factor for developing chronic complication such as cardiovascular diseases if not well controlled. Studies have shown that individuals with diabetes can make a positive impact on the outcomes of their disease by participating to their healthcare. Contextualized innovative and effective applications are needed to facilitate individuals with diabetes to participate to their care. Aim: To assess the effectiveness of Smartphone Application "GororokApp" in monitoring of glucose control among type 2 diabetes individuals. Materials & Methods: A Randomized Controlled Trial (RCT) was used to assess the effectiveness of smartphone application (GororokApp) in monitoring of glucose control for self-management by the patients with type 2 diabetes in Rwanda. Participants in intervention group used the GororokApp and recorded their blood glucose measurements and received health care advice remotely while the control group continued routine care. The participants were followed up over a period of 12 weeks. The primary outcomes were glycated haemoglobin, and daily blood glucose measurements. Results: After 12 weeks of follow up, the intervention and control, groups demonstrated difference of changes in glycated haemoglobin; whereby in the intervention group the glycated haemoglobin reduced from 8.45±2.93 to 6.89±1.86 (p ≤ 0.001), whereas in the control group the glycated haemoglobin increased from 7.12±2.52 to 8.14±2.17 (p ≤0.001). Conclusion: The smartphone application "GororokApp" is effective in self-monitoring and management of the daily blood glucose levels in intervention group to achieve treatment targets of blood glucose and glycated haemoglobin among individuals with type 2 diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.